Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Influenza (quadrivalent, split virion) vaccine by Changchun Institute of Biological Products for Influenza A Virus, H1N1 Subtype Infections: Likelihood of Approval
Influenza (quadrivalent, split virion) vaccine is under clinical development by Changchun Institute of Biological Products and currently in Phase I...
Influenza (quadrivalent, split virion) vaccine by Changchun Institute of Biological Products for Influenzavirus B Infections: Likelihood of Approval
Influenza (quadrivalent, split virion) vaccine is under clinical development by Changchun Institute of Biological Products and currently in Phase I...
Influenza (quadrivalent, split virion) vaccine by Changchun Institute of Biological Products for Influenza A Virus, H3N2 Subtype Infections: Likelihood of Approval
Influenza (quadrivalent, split virion) vaccine is under clinical development by Changchun Institute of Biological Products and currently in Phase I...